BioSpace News Archive

Press Releases

Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026

March 23, 2026
·
5 min read
Press Releases

Almirall’s 17th Skin Academy Highlights Scientific Advances in Inflammatory Skin Diseases and Skin Cancer, Patient-Reported Outcomes, and Holistic Care in Medical Dermatology

March 23, 2026
·
7 min read
Press Releases

ImmunityBio Announces Approval in Macau SAR, China for ANKTIVA® in BCG-Unresponsive NMIBC with CIS ± Papillary Tumors

March 23, 2026
·
5 min read
Press Releases

Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET

March 23, 2026
·
4 min read
Press Releases

argenx announces Annual General Meeting of Shareholders on May 6, 2026

March 23, 2026
·
3 min read
Press Releases

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - March 20, 2026

March 23, 2026
·
1 min read
Press Releases

XTL Biopharmaceuticals Announces ADS Ratio Change

March 23, 2026
·
4 min read
Press Releases

Imaginostics Receives Siemens Healthineers Letter of Support as Companies Advance Quantitative MRI Dialogue

March 23, 2026
·
1 min read
Press Releases

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - March 20, 2026

March 23, 2026
·
3 min read
Press Releases

Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)

March 23, 2026
·
6 min read